?磷酸化原癌蛋白CBL2抗体Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The proto oncogene c CBL was initially identified as the cellular homologue of v CBL oncogene that induces pre B cell lymphomas and myeloid leukemias in mice. In more recent studies CBL has been shown to be a negative regulator of tyrosine kinase signaling. 磷酸化原癌蛋白CBL2抗体The ubiquitin ligase activity of CBL leads to the degradation of tyrosine kinases, thus attenuating the signal of receptors. Targets of CBL include activated protein tyrosine kinases belonging to the Src and Syk/Zap 70 families. An additional mechanism to attenuate receptor signaling is thought to be achieved by CBL’s interaction with downstream targets of tyrosine kinases, such as PI 3K and Vav.
磷酸化原癌蛋白CBL2抗体Also known as:
phospho-C CBL (Tyr731); CBL2 (phospho-Tyr731); CBL2 (phospho-Tyr731); p-CBL2 (Tyr731); p-CBL2 (Y731); C CBL; Cas-Br-M (murine) ecotropic retroviral transforming sequence; Casitas B lineage lymphoma proto oncogene; CBL 2;E3 ubiquitin protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; RGD1561386; RING finger protein 55; RNF55v Signal transduction protein CBL; 磷酸化原癌蛋白CBL2抗体4732447J05Rik; CBL_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, .
●
Immunogen: KLH conjugated Synthesised phosphopeptide derived from human CBL2 around the phosphorylation site of Tyr731.
●
磷酸化原癌蛋白CBL2抗体Predicted Molecular Weight: 100kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl031Mu01凋亡相关因子配体(FASL)多克隆抗体Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Po01凋亡相关因子配体(FASL)多克隆抗体Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Ra01凋亡相关因子配体(FASL)多克隆抗体Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl031Si01凋亡相关因子配体(FASL)多克隆抗体Polyclonal Antibody to Factor Related Apoptosis Ligand (FASL)
kl032Bo01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Cp01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Ga01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Hu01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Mu01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Po01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl032Ra01酸性成纤维细胞生长因子(FGF1)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 1, Acidic (FGF1)
kl033Bo01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Ca01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Eq01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Ga01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Po01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Rb51干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl033Si01干扰素α(IFNα)多克隆抗体Polyclonal Antibody to Interferon Alpha (IFNa)
kl034Bo01成纤维细胞生长因子4(FGF4)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4)
kl034Ga01成纤维细胞生长因子4(FGF4)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4)
kl034Hu01成纤维细胞生长因子4(FGF4)多克隆抗体Polyclonal Antibody to Fibroblast Growth Factor 4 (FGF4)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话